Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiarko Pharmaceutical is a prominent Chinese pharmaceutical group specializing in the development and large-scale production of steroid hormone APIs and intermediates. Established in 1993 and based in Changzhou, the company has grown into one of the world's largest manufacturing bases for steroids, including corticosteroids, progestogens, estrogens, and androgens. Their extensive product portfolio features essential compounds such as progesterone, hydrocortisone, and spironolactone, manufactured in compliance with international GMP standards. In addition to its role as a global supplier, Jiarko provides comprehensive CDMO services, utilizing advanced chemical synthesis and microbial fermentation technologies. The company serves a diverse international clientele, exporting products to markets in Europe, North America, and Southeast Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changzhou Jiarko Pharmaceutical Group.